As part of the transaction, BC Partners’ advised funds will reinvest in Aenova alongside Kühne Holding AG and continue to support the company as a minority shareholder.
Aenova Group, headquartered in Starnberg near Munich, Germany, is a leading global contract manufacturer and development service provider for the pharmaceutical and healthcare industry. With approximately 4,000 employees in 14 manufacturing sites worldwide, the company is a one-stop service provider for the development, manufacturing, and packaging of drug products for pharma companies around the globe.
LEGAL DESIRE NEWSLETTER
Where the legal industry reads first.
Enjoyed this article? Get the biggest legal industry updates, deals, appointments, insights and expert interviews in your inbox, free.
No spam. Unsubscribe anytime.
